These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 15505173

  • 21. Are generic drugs really inferior medicines?
    Moore N, Berdaï D, Bégaud B.
    Clin Pharmacol Ther; 2010 Sep; 88(3):302-4. PubMed ID: 20725079
    [Abstract] [Full Text] [Related]

  • 22. Brand-to-generic levetiracetam switch in patients with epilepsy in a routine clinical setting.
    Markoula S, Chatzistefanidis D, Gatzonis S, Siatouni A, Siarava E, Verentzioti A, Kyritsis AP, Patsalos PN.
    Seizure; 2017 May; 48():1-6. PubMed ID: 28363098
    [Abstract] [Full Text] [Related]

  • 23. [Generic drugs in the treatment of epilepsy].
    González de Dios J, Ochoa-Sangrador C, Sempere AP.
    Rev Neurol; 2017 May; 41(11):676-83. PubMed ID: 16317637
    [Abstract] [Full Text] [Related]

  • 24. Is generic prescribing acceptable in epilepsy?
    Besag FM.
    Drug Saf; 2000 Sep; 23(3):173-82. PubMed ID: 11005701
    [Abstract] [Full Text] [Related]

  • 25. No gender effect on binding characteristics of phenytoin to serum proteins in monotherapy for adult patients with epilepsy.
    Kodama H, Kodama Y, Shinozawa S, Kanemaru R, Todaka K, Mitsuyama Y.
    Am J Ther; 2000 Sep; 7(5):285-9. PubMed ID: 11317172
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. In vivo binding characteristics of phenytoin to serum proteins in monotherapy pediatric patients with epilepsy.
    Kodama H, Kodama Y, Shinozawa S, Kanemaru R, Itokazu N, Sugimoto T.
    Int J Clin Pharmacol Ther; 2000 Jan; 38(1):25-9. PubMed ID: 10667833
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Generic antiepileptic drugs-Safe or harmful in patients with epilepsy?
    Holtkamp M, Theodore WH.
    Epilepsia; 2018 Jul; 59(7):1273-1281. PubMed ID: 29894004
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Generic anticonvulsant use in children: do we have evidence to recommend brand formulations?
    Hamiwka LD.
    Arch Neurol; 2009 Nov; 66(11):1417-8. PubMed ID: 19901177
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The value of specifying brand-name antiepileptic drugs.
    Ng YT.
    Arch Neurol; 2009 Nov; 66(11):1415-6. PubMed ID: 19901176
    [No Abstract] [Full Text] [Related]

  • 38. Peri-operative prophylaxis with phenytoin: dosage and therapeutic plasma levels.
    Levati A, Savoia G, Zoppi F, Boselli L, Tommasino C.
    Acta Neurochir (Wien); 1996 Nov; 138(3):274-8; discussion 278-9. PubMed ID: 8861695
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.